Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Report

Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Analysis Report By Source, By Service (Upstream, Downstream, Fill/Finish), By Product (Biologics), By Region And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-2-68038-698-1
  • Number of Pages: 193
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Table of Content

Chapter 1 Biopharmaceuticals Contract Manufacturing Market: Executive Summary
                  1.1 Market Snapshot
Chapter 2 Biopharmaceuticals Contract Manufacturing Market: Research Methodology
                  2.1 Information Procurement
                      2.1.1 Purchased Database
                      2.1.2 GVR’s Internal Database
                  2.2 Data Analysis
                  2.3 Market Formulation & Validation
                  2.4 Approaches for Market Estimation
                      2.4.1 Approach 1: Commodity Flow & Bottom Up Approach
                      2.4.2 Approach 2: Top Down and Parent Market Analysis
Chapter 3 Biopharmaceuticals Contract Manufacturing Market: Variables, Trends& Scope
                  3.1 Market Segmentation &Scope
                      3.1.1 Market driver analysis
                          3.1.1.1 Rise in investment by CMOs for capacity expansion
                          3.1.1.2 Commercial success of biopharmaceuticals and consequent increase in demand for biopharmaceuticals
                              3.1.1.2.1 Notable growth of biologics
                          3.1.1.3 Robust biopharmaceuticals pipeline
                          3.1.1.4 Cost and time saving benefits offered by contract services
                      3.1.2 Market restraint analysis
                          3.1.2.1 Limited outsourcing amongst well-established biopharmaceutical manufacturer
                  3.2 Opportunity analysis
                      3.2.1 Expansion of fill-and-finish CMOs
                      3.2.2 Emergence of single-use bioprocessing equipment & solutions
                      3.2.3 Funding & investments
                  3.3 Trend Analysis
                      3.3.1 Merger & acquisitions in CMO industry
                      3.3.2 Trading of CMOs at strong EV/EBITDA multiples
                      3.3.3 Current trends in biopharmaceutical industry
                  3.4 Pipeline Analysis
                      3.4.1 Distribution of products & projects in development stage by clinical phase
                          3.4.1.1 Key finding of the analysis:
                      3.4.2 Pipeline analysis for biosimilar drugs, as of February 2018
                      3.4.3 Total global biopharmaceutical R&D spending
                      3.4.4 Number of drugs in clinical development phase, 2015
                  3.5 Pricing Analysis for Process Development
                      3.5.1 Cell line/expression system pricing
                      3.5.2 Bioreactor cost
                      3.5.3 Operating and construction cost advantage due to single-use bioprocessing equipment
                      3.5.4 Bioprocessing operating cost items and ranges
                      3.5.5 Bioprocessing pricing analysis based on product type
                      3.5.6 Downstream bioprocessing pricing analysis
                          3.5.6.1 Cost analyses for buffer purchasing
                  3.6 Penetration &Growth Prospect Mapping for Contract Manufacturing Service, 2021
                  3.7 Biopharmaceuticals Contract Manufacturing Market -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
                  3.8 Industry Analysis - Porter’s
                  3.9 Customer Relationship Management in Contract Manufacturing
                      3.9.1 Selection process of CMO
                      3.9.2 Operations and quality oversight of CMOs
Chapter 4 Biopharmaceuticals Contract Manufacturing Market: Source Estimates & Trend Analysis
                  4.1 Global Biopharmaceuticals Contract Manufacturing Market: Source Movement Analysis
                  4.2 Mammalian Source
                      4.2.1 Global mammalian source market, 2017 - 2030 (USD Million)
                  4.3 Non-mammalian Source
                      4.3.1 Global non-mammalian source market, 2017 - 2030 (USD Million)
Chapter 5 Biopharmaceuticals Contract Manufacturing Market: Service Estimates & Trend Analysis
                  5.1 Global Biopharmaceuticals Contract Manufacturing Market: Service Movement Analysis
                  5.2 Process development
                      5.2.1 Global process development market, 2017 - 2030 (USD Million)
                      5.2.2 Downstream processing
                          5.2.2.1 Global downstream processing market, 2017 - 2030 (USD Million)
                      5.2.3 Upstream processing
                          5.2.3.1 Global upstream processing market, 2017 - 2030 (USD Million)
                  5.3 Fill & finish operations
                      5.3.1 Global fill & finish operations market, 2017 - 2030 (USD Million)
                  5.4 Analytical & QC studies
                      5.4.1 Global analytical & QC studies market, 2017 - 2030 (USD Million)
                  5.5 Packaging
                      5.5.1 Global contract packaging market, 2017 - 2030 (USD Million)
Chapter 6 Biopharmaceuticals Contract Manufacturing Market: Product Estimates & Trend Analysis
                  6.1 Global Biopharmaceuticals Contract Manufacturing Market: Product Movement Analysis
                  6.2 Biologics
                      6.2.1 Global biologics market, 2017 - 2030 (USD Million)
                      6.2.2 Monoclonal Antibodies
                          6.2.2.1 Global monoclonal antibodies market, 2017 - 2030 (USD Million)
                      6.2.3 Recombinant proteins
                          6.2.3.1 Global recombinant proteins market, 2017 - 2030 (USD Million)
                      6.2.4 Vaccines
                          6.2.4.1 Global vaccines market, 2017 - 2030 (USD Million)
                  6.3 Antisense, RNAi, & molecular therapy
                      6.3.1 Global antisense, RNAi, & molecular therapy market, 2017 - 2030 (USD Million)
                      6.3.2 Others
                          6.3.2.1 Global other product market, 2017 - 2030 (USD Million)
                  6.4 Biosimilar
                          6.4.1 Global biosimilar market, 2017 - 2030 (USD Million)
Chapter 7 Biopharmaceuticals Contract Manufacturing Market: Therapeutic area Estimates & Trend Analysis
                  7.1 Global Biopharmaceuticals Contract Manufacturing Market: Therapeutic Area Movement Analysis
                  7.2 Oncology
                      7.2.1 Global oncology market, 2017 - 2030 (USD Million)
                  7.3 Autoimmune Diseases
                      7.3.1 Global autoimmune diseases market, 2017 - 2030 (USD Million)
                  7.4 Metabolic Diseases
                      7.4.1 Global metabolic diseases market, 2017 - 2030 (USD Million)
                  7.5 Cardiovascular Diseases
                      7.5.1 Global cardiovascular diseases market, 2017 - 2030 (USD Million)
                  7.6 Neurology
                      7.6.1 Global neurology market, 2017 - 2030 (USD Million)
                  7.7 Infectious Diseases
                      7.7.1 Global infectious diseases market, 2017 - 2030 (USD Million)
                  7.8 Others
                      7.8.1 Global others market, 2017 - 2030 (USD Million)
Chapter 8 Biopharmaceuticals Contract Manufacturing Market: Regional Estimates & Trend Analysis, by Service, Source, & Product
                  8.1 Biopharmaceuticals Contract Manufacturing Market Share by Region, 2021 & 2030
                  8.2 North America
                      8.2.1 North America biopharmaceuticals contract manufacturing market, 2018 - 2030 (USD Million)
                      8.2.2 U.S.
                          8.2.2.1 U.S. biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.2.2.2 U.S. biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.2.2.3 U.S. biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.2.2.4 U.S. biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
                      8.2.3 Canada
                          8.2.3.1 Canada biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.2.3.2 Canada biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.2.3.3 Canada biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.2.3.4 Canada biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
                  8.3 Europe
                      8.3.1 Europe biopharmaceuticals contract manufacturing market, 2018 - 2030 (USD Million)
                      8.3.2 Germany
                          8.3.2.1 Germany biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.3.2.2 Germany biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.3.2.3 Germany biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.3.2.4 Germany biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
                      8.3.3 France
                          8.3.3.1 France biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.3.3.2 France biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.3.3.3 France biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.3.3.4 France biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
                      8.3.4 UK
                          8.3.4.1 UK biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.3.4.2 UK biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.3.4.3 UK biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.3.4.4 UK biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
                      8.3.5 Italy
                          8.3.5.1 Italy biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.3.5.2 Italy biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.3.5.3 Italy biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.3.5.4 Italy biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
                      8.3.5 Spain
                          8.3.5.1 Spain biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.3.5.2 Spain biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.3.5.3 Spain biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.3.5.4 Spain biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
                  8.4 Asia Pacific
                      8.4.1 Asia Pacific biopharmaceuticals contract manufacturing market, 2018 - 2030 (USD Million)
                      8.4.2 China
                          8.4.2.1 China biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.4.2.2 China biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.4.2.3 China biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.4.2.4 China biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
                      8.4.3 India
                          8.4.3.1 India biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.4.3.2 India biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.4.3.3 India biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.4.3.4 India biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
                      8.4.4 Japan
                          8.4.4.1 Japan biopharmaceuticals contract manufacturing market, by source, 2018 - 2040 (USD Million)
                          8.4.4.2 Japan biopharmaceuticals contract manufacturing market, by service, 2018 - 2040 (USD Million)
                          8.4.3.4 Japan biopharmaceuticals contract manufacturing market, by product, 2018 - 2040 (USD Million)
                          8.4.4.4 Japan biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2030 (USD Million)
                      8.4.5 Australia
                          8.4.5.1 Australia biopharmaceuticals contract manufacturing market, by source, 2018 - 2050 (USD Million)
                          8.4.5.2 Australia biopharmaceuticals contract manufacturing market, by service, 2018 - 2050 (USD Million)
                          8.4.5.3 Australia biopharmaceuticals contract manufacturing market, by product, 2018 - 2050 (USD Million)
                          8.4.5.4 Australia biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2050 (USD Million)
                      8.4.6 South Korea
                          8.4.6.1 South Korea biopharmaceuticals contract manufacturing market, by source, 2018 - 2060 (USD Million)
                          8.4.6.2 South Korea biopharmaceuticals contract manufacturing market, by service, 2018 - 2060 (USD Million)
                          8.4.6.3 South Korea biopharmaceuticals contract manufacturing market, by product, 2018 - 2060 (USD Million)
                          8.4.6.4 South Korea biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2060 (USD Million)
                  8.5 Latin America
                      8.5.1 Latin America biopharmaceuticals contract manufacturing market, 2018 - 2030 (USD Million)
                      8.5.2 Brazil
                          8.5.2.1 Brazil biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.5.2.2 Brazil biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.5.2.3 Brazil biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.5.2.4 Brazil biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2060 (USD Million)
                      8.5.3 Colombia
                          8.5.3.1 Colombia biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.5.3.2 Colombia biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.5.3.3 Colombia biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.5.3.4 Colombia biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2060 (USD Million)
                      8.5.4 Argentina
                          8.5.4.1 Argentina biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.5.4.2 Argentina biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.5.4.3 Argentina biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.5.4.4 Argentina biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2060 (USD Million)
                      8.5.5 Mexico
                          8.5.5.1 Mexico biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.5.5.2 Mexico biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.5.5.3 Mexico biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.5.5.4 Mexico biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2060 (USD Million)
                  8.6 Middle East & Africa (MEA)
                      8.6.1 Middle East & Africa biopharmaceuticals contract manufacturing market, 2018 - 2030 (USD Million)
                      8.6.2 South Africa
                          8.6.2.1 South Africa biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.6.2.2 South Africa biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.6.2.3 South Africa biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.6.2.4 South Africa biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2060 (USD Million)
                      8.6.3 Saudi Arabia
                          8.6.3.1 Saudi Arabia biopharmaceuticals contract manufacturing market, by source, 3018 - 3030 (USD Million)
                          8.6.3.2 Saudi Arabia biopharmaceuticals contract manufacturing market, by service, 3018 - 3030 (USD Million)
                          8.6.3.3 Saudi Arabia biopharmaceuticals contract manufacturing market, by product, 3018 - 3030 (USD Million)
                          8.6.3.4 Saudi Arabia biopharmaceuticals contract manufacturing market, by therapeutic area, 3018 - 3060 (USD Million)
                      8.6.4 UAE
                          8.6.4.1 UAE biopharmaceuticals contract manufacturing market, by source, 2018 - 2030 (USD Million)
                          8.6.4.2 UAE biopharmaceuticals contract manufacturing market, by service, 2018 - 2030 (USD Million)
                          8.6.4.3 UAE biopharmaceuticals contract manufacturing market, by product, 2018 - 2030 (USD Million)
                          8.6.4.4 UAE biopharmaceuticals contract manufacturing market, by therapeutic area, 2018 - 2060 (USD Million)
Chapter 9 Competitive Landscape
                  9.1 Strategy Framework
                  9.2 Market Participation Categorization
                  9.3 Company Profiles
                      9.3.1 Boehringer Ingelheim GmbH
                          9.3.1.1 Company overview
                          9.3.1.2 Financial performance
                          9.3.1.3 Product benchmarking
                          9.3.1.4 Strategic initiatives
                      9.3.2 Lonza
                          9.3.2.1 Company overview
                          9.3.2.2 Financial performance
                          9.3.2.3 Product benchmarking
                          9.3.2.4 Strategic initiatives
                      9.3.3 Inno Biologics Sdn Bhd
                          9.3.3.1 Company overview
                          9.3.3.2 Financial performance
                          9.3.3.3 Product benchmarking
                          9.3.3.4 Strategic initiatives
                      9.3.4 Rentschler Biotechnologie GmbH
                          9.3.4.1 Company overview
                          9.3.4.2 Financial performance
                          9.3.4.3 Product benchmarking
                          9.3.4.4 Strategic initiatives
                      9.3.5 JRS PHARMA
                          9.3.5.1 Company overview
                              9.3.5.1.1 CELONIC AG
                          9.3.5.2 Financial performance
                              9.3.5.2.1 Financial performance
                          9.3.5.3 Product benchmarking
                          9.3.5.4 Strategic initiatives
                      9.3.6 AGC Biologics
                          9.3.6.1 Company overview
                          9.3.6.2 BIOMEVA GmbH
                              9.3.6.2.1 Company overview
                          9.3.6.3 CMC Biologics
                              9.3.6.3.1 Company overview
                          9.3.6.4 Financial performance of AGC
                              9.3.6.4.1 Financial performance of BIOMEVA GmbH
                              9.3.6.4.2 Financial performance of CMC Biologics
                          9.3.6.5 Product benchmarking
                          9.3.6.6 Strategic initiatives
                              9.3.6.6.1 Biomeva GmbH
                              9.3.6.6.2 CMC Biologics
                      9.3.7 ProBioGen
                          9.3.7.1 Company overview
                          9.3.7.2 Financial performance
                          9.3.7.3 Product benchmarking
                          9.3.7.4 Strategic initiatives
                      9.3.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
                          9.3.8.1 Company overview
                          9.3.8.2 Financial performance
                          9.3.8.3 Product benchmarking
                          9.3.8.4 Strategic initiatives
                      9.3.9 TOYOBO CO., LTD.
                          9.3.9.1 Company overview
                          9.3.9.2 Financial performance
                          9.3.9.3 Product benchmarking
                          9.3.9.4 Strategic initiatives
                      9.3.10 Samsung BioLogics
                          9.3.10.1 Company overview
                          9.3.10.2 Financial performance
                          9.3.10.3 Product benchmarking
                          9.3.10.4 Strategic initiatives
                      9.3.11 Thermo Fisher Scientific, Inc.
                          9.3.11.1 Company Overview
                          9.3.11.2 Patheon
                              9.3.11.2.1 Company overview
                                  9.3.11.1.1.1 DPx
                          9.3.11.3 Financial Performance of Thermo Fisher Scientific, Inc.
                              9.3.11.3.1 Financial performance of Patheon
                          9.3.11.4 Product benchmarking
                          9.3.11.5 Strategic initiatives
                      9.3.12 Binex Co., Ltd.
                          9.3.12.1 Company overview
                          9.3.12.2 Financial performance
                          9.3.12.3 Product benchmarking
                      9.3.13 WuXi Biologics
                          9.3.13.1 Company overview
                          9.3.13.2 Financial performance
                          9.3.13.3 Product benchmarking
                          9.3.13.4 Strategic initiatives
                      9.3.14 AbbVie, Inc.
                          9.3.14.1 Company overview
                          9.3.14.2 Financial performance
                          9.3.14.3 Product benchmarking
                          9.3.14.4 Strategic initiatives
                      9.3.15 Novartis AG
                          9.3.15.1 Company overview
                          9.3.15.2 Financial performance
                          9.3.15.3 Product benchmarking
                          9.3.15.4 Strategic initiatives
                      9.3.16 ADMA Biologics, Inc.
                          9.3.16.1 Company overview
                          9.3.16.2 Financial performance
                          9.3.16.3 Product benchmarking
                          9.3.16.4 Strategic initiatives
                      9.3.17 Catalent Inc.
                          9.3.17.1 Company overview
                          9.3.17.2 Financial performance
                          9.3.17.3 Product benchmarking
                          9.3.17.4 Strategic initiatives
                      9.3.18 Cambrex Corporation
                          9.3.18.1 Company overview
                          9.3.18.2 Financial performance
                          9.3.18.3 Product benchmarking
                          9.3.18.4 Strategic initiatives
                      9.3.19 Pfizer Inc.
                          9.3.19.1 Company overview
                          9.3.19.2 Financial performance
                          9.3.19.3 Product benchmarking
                          9.3.19.4 Strategic initiatives
                      9.3.20 Siegfried Holding AG
                          9.3.20.1 Company overview
                          9.3.20.2 Financial performance
                          9.3.20.3 Product benchmarking
                          9.3.20.4 Strategic initiatives


List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviation


List of Figures

FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Cumulative success rate comparison of biologics with small molecules over time
FIG. 12 Number of biologics investigational new drugs, 2005 - 2015
FIG. 13 Number of reference products by U.S. biosimilars launchable dates
FIG. 14 Market restraint relevance analysis (Current & future impact)
FIG. 15 Risk associated with outsourcing services
FIG. 16 New technologies adopted by CMOs for fill/finish
FIG. 17 Major CMO consolidation deals in 2017
FIG. 18 CMOs are trading at strong EV/EBITDA multiples, as of 13 January 2017
FIG. 19 Trends in biopharmaceutical industry
FIG. 20 Steps in the estimation of capital investment and operating costs
FIG. 21 Capital expenditure comparison between SUT and SS-based biologic manufacturing
FIG. 22 Operating expense comparison between SUT and SS-based biologic manufacturing
FIG. 23 Operating expense-labor comparison between SUT and SS-based biologic manufacturing
FIG. 24 Distribution, average USD cost per gram for recombinant protein, 2017 (14th annual survey of 227 biopharmaceutical manufacturing professionals)
FIG. 25 Penetration & growth prospect mapping for contract manufacturing service, 2017
FIG. 26 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 27 Porter’s Five Forces Analysis
FIG. 28 Global biopharmaceuticals contract manufacturing market: Source outlook key takeaways
FIG. 29 Global biopharmaceuticals contract manufacturing market: Source movement analysis
FIG. 30 Global mammalian source market, 2017 - 2030 (USD Million)
FIG. 31 Global non-mammalian source market, 2017 - 2030 (USD Million)
FIG. 32 Global biopharmaceuticals contract manufacturing market: Contract manufacturing service type outlook key takeaways
FIG. 33 Global biopharmaceuticals contract manufacturing market: Contract manufacturing service type movement analysis
FIG. 34 Percentage of bio manufacturers outsourcing some activity of upstream and downstream processing, 2011–2016
FIG. 35 Global process development market, 2017 - 2030 (USD Million)
FIG. 36 Global downstream processing market, 2017 - 2030 (USD Million)
FIG. 37 Global upstream processing market, 2017 - 2030 (USD Million)
FIG. 38 Global fill & finish operations market, 2017 - 2030 (USD Million)
FIG. 39 Global analytical & QC studies market, 2017 - 2030 (USD Million)
FIG. 40 Global contract packaging market, 2017 - 2030 (USD Million)
FIG. 41 Global biopharmaceuticals contract manufacturing market: Product outlook key takeaways
FIG. 42 Global biopharmaceuticals contract manufacturing market: Product movement analysis
FIG. 43 Global biologics market, 2017 - 2030 (USD Million)
FIG. 44 Year-wise annual approvals for MAb products that are currently marketed in the U.S./EU
FIG. 45 Share of MAb-related R&D programs at different development phases, 2015
FIG. 46 Global monoclonal antibodies market, 2017 - 2030 (USD Million)
FIG. 47 Comparison of R&D pipeline expansion in 2014 and 2015 for recombinant products
FIG. 48 Global recombinant proteins market, 2017 - 2030 (USD Million)
FIG. 49 Global vaccines market, 2017 - 2030 (USD Million)
FIG. 50 Global antisense, RNAi, &molecular therapy market, 2017 - 2030 (USD Million)
FIG. 51 Global other product market, 2017 - 2030 (USD Million)
FIG. 52 Global biosimilar market, 2017 - 2030 (USD Million)
FIG. 53 Global biopharmaceuticals contract manufacturing market: Therapeutic area outlook key takeaways
FIG. 54 Global biopharmaceuticals contract manufacturing market: Therapeutic area movement analysis
FIG. 55 Global oncology market, 2017 - 2030 (USD Million)
FIG. 56 Global autoimmune diseases market, 2017 - 2030 (USD Million)
FIG. 57 Global metabolic diseases market, 2017 - 2030 (USD Million)
FIG. 58 Global cardiovascular diseases market, 2017 - 2030 (USD Million)
FIG. 59 Global neurology market, 2017 - 2030 (USD Million)
FIG. 60 Global infectious diseases market, 2017 - 2030 (USD Million)
FIG. 61 Global others market, 2017 - 2030 (USD Million)
FIG. 62 Regional market place: Key takeaway
FIG. 63 Comparison of biopharmaceutical manufacturing facilities region and country wise
FIG. 64 Biopharmaceuticals contract manufacturing regional outlook, 2021 & 2030
FIG. 65 North America biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 66 Number of U.S. pharmaceutical outsourcing M&A transactions
FIG. 67 Biopharmaceuticals goods export growth comparison between 2011 and 2014
FIG. 68 U.S. biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 69 Pros and cons of Canadian pharmaceutical & biopharmaceutical market
FIG. 70 Canada Biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 71 Europe biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 72 Revenue growth of Germany pharmaceutical industry
FIG. 73 Germany biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 74 France biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 75 UK biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 76 Italy biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 77 Spain biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 78 Factors supporting contract manufacturing/research in Asian countries
FIG. 79 Asia Pacific biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 80 China Biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 81 India biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 82 Japan biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 83 South Korea biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 84 Australia biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 85 Latin America biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 86 Brazil biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 87 Mexico biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 88 Colombia biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 89 Argentina biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 90 Middle East & Africa biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 91 South Africa biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 92 Saudi Arabia biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 93 UAE biopharmaceuticals contract manufacturing market, 2017 - 2030 (USD Million)
FIG. 94 Strategy framework
FIG. 95 Participant categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon